Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?
- PMID: 30870157
- PMCID: PMC6799989
- DOI: 10.1097/ALN.0000000000002653
Is a Part Better than the Whole for Cell-based Therapy for Acute Respiratory Distress Syndrome?
Comment on
-
Extracellular Vesicles from Interferon-γ-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats.Anesthesiology. 2019 May;130(5):778-790. doi: 10.1097/ALN.0000000000002655. Anesthesiology. 2019. PMID: 30870158
References
-
- Thompson BT; Chambers RC; Liu KD, Acute Respiratory Distress Syndrome. N Engl J Med 2017, 377 (6), 562–572. - PubMed
-
- Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD, Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med 2018, In Press. - PMC - PubMed
-
- Millar FR; Summers C; Griffiths MJ; Toshner MR; Proudfoot AG, The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities. Thorax 2016, 71 (5), 462–73. - PubMed
-
- Varkouhi A; Jerkic M; Ormesher L; Gagnon S; Goyal S; Rabani R; Masterson C; Spring C; Chen P; Gu F; dos Santos C; Curley G; Laffey J, Extracellular Vesicles from interferon-y primed human umbilical cord mesenchymal stromal cells reduce E.coli acute lung injury in rats. Anesthesiology 2019, In Press. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
